In early 2024, OpenAI CEO Sam Altman made a bold prediction: the world would soon see its first one-person, billion-dollar company. This week, a New York Times profile of Matthew Gallagher and his telehealth startup, Medvi, suggests that the era of the "solo unicorn" has officially arrived.
Launched from a Los Angeles living room in late 2024 with just $20,000, Medvi has achieved a scale that traditionally required thousands of employees. In its first full year, the company generated $401 million in sales. It is now on track to hit $1.8 billion in revenue for 2026—all with a full-time headcount of exactly two: Gallagher and his brother, Elliot.
The AI "Operating System"
Gallagher didn’t build Medvi by hiring engineers, marketers, or customer support reps. Instead, he treated a suite of AI tools as his "full-stack" staff. He used ChatGPT, Claude, and Grok to write the platform's code; Midjourney and Runway to generate thousands of video and image advertisements; and ElevenLabs to power voice-based customer service.
To handle the "physical" world, Gallagher plugged his AI-driven front end into existing infrastructure. Companies like OpenLoop and CareValidate provide the actual licensed physicians, pharmacies, and shipping logistics. By "renting" the hard parts and automating the growth layer, Gallagher achieved a 16.2% net profit margin—nearly triple that of established competitors like Hims & Hers, which employs over 2,400 people.
Friction in the Machine
The rise of Medvi isn’t without controversy. The company’s explosive growth is fueled by the massive demand for GLP-1 weight-loss drugs (like compounded Semaglutide), a market so hot that critics argue the product—not the AI—is the real secret sauce.
Furthermore, the "hands-off" model has shown cracks. Medvi's AI chatbots have famously "hallucinated" drug prices and non-existent product lines, forcing Gallagher to step in as the sole human backstop. More seriously, the FDA recently issued a warning letter to the company regarding its marketing claims, and some observers have pointed out that many of the "doctors" in Medvi's early ads were AI-generated personas.
A New Blueprint
Regardless of the ethical debates, Medvi represents a fundamental shift in capitalism. It proves that in the AI age, the "middleman" has been hyper-charged. By using AI to compress an entire corporate hierarchy into a single laptop, Gallagher has turned the traditional startup playbook on its head, moving from "move fast and break things" to "move solo and scale everything."
source : New York Times